Piacquad David
SEC insider (Form 3/4/5 filer). CIK 0001602343. Director at Neumora Therapeutics, Inc. (NMRA). 10 reported Form 4/5 transactions since Sep 2024; latest on May 27, 2026. Located in WATERTOWN, MA.
Companies Piacquad David has filed insider reports for
- Neumora Therapeutics, Inc. (NMRA): Director
Piacquad David
CIK: 0001602343
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Neumora Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- May 27, 2026NMRA
Neumora Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
80K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
28.6K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
46.5K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
28.6K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
80K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
46.5K shares- - Feb 13, 2025NMRA
Neumora Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
28.6K shares- - Feb 13, 2025NMRA
Neumora Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
46.5K shares- - Feb 13, 2025NMRA
Neumora Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
28.6K shares- - Feb 13, 2025NMRA
Neumora Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
46.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 27, 2026 | NMRA Neumora Therapeutics, Inc. | Award Stock Option (Right to Buy) | 80,000 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 28,571 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Award Stock Option (Right to Buy) | 46,455 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Award Stock Option (Right to Buy) | 28,571 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Award Stock Option (Right to Buy) | 80,000 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 46,455 | - | - | Direct |
| Feb 13, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 28,571 | - | - | Direct |
| Feb 13, 2025 | NMRA Neumora Therapeutics, Inc. | Award Stock Option (Right to Buy) | 46,455 | - | - | Direct |
| Feb 13, 2025 | NMRA Neumora Therapeutics, Inc. | Award Stock Option (Right to Buy) | 28,571 | - | - | Direct |
| Feb 13, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 46,455 | - | - | Direct |
1-10 of 10 transactions